The occurrence of a somatic variant in the CEBPA gene, known as the “second hit”, is the mechanism leading to AML in patients carrying a germline CEBPA variant, as confirmed in this pedigree. The gene discussed is CEBPA; the disease is acute myeloid leukemia.